Market Size of Peristaltic Pumps Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 6.10 % |
| Fastest Growing Market | North America |
| Largest Market | Asia-Pacific |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Peristaltic Pumps Market Analysis
The peristaltic pumps market is expected to register a CAGR of 6.1% during the forecast period.
The pharmaceutical and medical end-use industries drove the demand for peristaltic pumps while producing the COVID-19 vaccine. A peristaltic pump is ideal for preparing viral transport medium (VTM) tubes for COVID-19 testing as it can aliquot medium into individual, sterile screw-capped tubes quickly and efficiently. The pump's enclosed liquid system, easily sterilizable tubing, and lack of valves or seals reduce the risk of contamination to the product and the pump itself. Growing initiatives from key market players further drove the market during the pandemic. For instance, in September 2021, the US lab products provider Avantor planned to buy Masterflex from privately held Antylia Scientific to increase its COVID-19 therapy and vaccine manufacturing operations. Masterflex manufactures products like peristaltic pumps used to research and produce biological drugs, vaccines, and cell and gene therapies. Such initiatives also drove the market during the pandemic. Currently, the market is losing traction, with the number of COVID-19 cases declining. However, it is expected to have stable growth during the forecast period.
Rising investments in expanding water wastewater treatment plants worldwide and increasing investments in drug development and discovery are boosting the market's growth.
The rising importance of peristaltic pumps in the pharmaceutical and biopharmaceutical industries is expected to drive the market. For instance, according to the study published in LabOnline in October 2021, peristaltic pumps offer a versatile solution to reduce cleaning requirements while preventing product contamination and facilitating equipment reconfiguration between batches. Thus, such benefits of peristaltic pumps in the preparation of formulation are anticipated to boost their demand in the pharmaceutical industry.
Increasing investments in drug development and discovery are anticipated to drive the market over the forecast period. Peristaltic pumps are used in the pharmaceutical and medical industries to make biological and medicinal products, process botanical drugs and herbs, isolate active medicinal principles, and make pharmaceutical products for internal and external consumption in various forms. According to a report published in September 2021 by the Pharmaceutical Research and Manufacturers of America (PhRMA), biopharmaceutical companies invested more than a trillion dollars in R&D in the last decade. Such substantial R&D investments are anticipated to drive the market's growth due to the rising adoption of peristaltic pumps in biopharma industries.
Various strategies adopted by key market players may drive the market over the projected period, such as product launches, mergers, and acquisitions. For instance, in August 2021, Watson-Marlow Fluid Technology Group (WMFTG) launched the next generation of its industry-leading Qdos chemical metering pumps. Qdos Conveying Wave Technology (CWT) enhanced peristaltic pump capabilities by providing a longer service life than traditional tube-based designs. Such launches are expected to propel the market's growth.
However, frequent replacement of hoses and tubes may restrain the market over the forecast period.
